About Valitacell
Valitacell is a company based in Dublin (Ireland) founded in 2014 was acquired by Beckman Coulter in September 2022. Valitacell has raised $1.45 million across 9 funding rounds from investors including Beckman Coulter, European Union and EIC Fund. Valitacell operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.45 M (USD)
in 9 rounds
-
Latest Funding Round
$841.42 K (USD), Grant
Jan 01, 2020
-
Investors
Beckman Coulter
& 3 more
-
Employee Count
Not available
-
Acquired by
Beckman Coulter
(Sep 13, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Valitacell
Valitacell has successfully raised a total of $1.45M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $841.42 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Valitacell
Valitacell has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Beckman Coulter, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
InterTradeIreland is focused on connecting businesses across Ireland for growth.
|
Locked | Locked | Locked |
Investor details for Valitacell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Valitacell
Investment portfolio details for Valitacell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Valitacell
Detailed financials for Valitacell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Valitacell Comparisons
Peer comparison for Valitacell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Valitacell
Valitacell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Developer of therapeutics for microbiome based diseases
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
Detailed competitors of Valitacell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Valitacell
Complete news archive for Valitacell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valitacell
Valitacell was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Valitacell is headquartered in Dublin, Ireland.
Valitacell is a funded company, having raised a total of $1.45M across 9 funding rounds to date.
Valitacell was founded in 2014 in Dublin, Ireland, within the biotechnology sector focused on cell-based manufacturing. High-throughput assays are offered to enhance process efficiency, including the Fluoroprotein platform for IgG concentration measurement and the ChemStress platform for simulating bioreactor stresses on host cells. Predictions of cell performance during early development stages are enabled through these technologies, supporting biopharmaceutical production.
Valitacell's top competitors include KBI Biopharma, Aldevron and Ovagen.
Valitacell has 4 investors. Key investors include Beckman Coulter, European Union, EIC Fund, and InterTradeIreland.